secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001104659-24-030997
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences regains Nasdaq compliance for minimum market value rule
----------------------------------------------------------------------------

- Received Nasdaq letter on March 5, 2024 confirming compliance with Listing Rule 5550(b)(2).
- Company maintained market value of common stock above $35M for 10 consecutive business days.
- Previous non-compliance notice received on December 6, 2023; matter now closed.
- Regains compliance before the June 3, 2024 deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924030997/0001104659-24-030997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924030997/tm248024d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-030997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer